Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
In 1966, Welborn et al. (1) studied 19 nondiabetic patients with essential hypertension and demonstrated that these individuals had significantly higher plasma insulin concentrations compared with a normotensive control group. Although these observations suggested that the prevalence of resistance to insulin-mediated glucose disposal would be increased in patients with essential hypertension, it wasn’t until approximately 20 yr later that several research groups demonstrated that this was the case (2–7). Although the relationship between insulin resistance, hyperinsulinemia, and essential hypertension has been extensively studied in the past 15 yr, questions continue to be raised as to the nature of the link between these variables. Indeed, there is not even consensus as to whether or not there is a physiological relationship between insulin resistance/compensatory hyperinsulinemia and blood pressure regulation. Another issue, and perhaps of greater clinical relevance, is whether the insulin resistance/compensatory hyperinsulinemia that is frequently present in patients with essential hypertension plays any role in the increased prevalence of cardiovascular disease (CVD) that is the major cause of morbidity and mortality in this clinical syndrome. The goals of this review are to address both of these issues. To begin with, the evidence in support of a role for insulin resistance and compensatory hyperinsulinemia in the pathogenesis of essential hypertension will be summarized…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, hypertension is an insulin-resistant state and PA is frequently associated with hypertension [25,26].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [26]
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
The pathogenesis of atherosclerosis
(1972) · American Heart Journal · doi:10.1016/0002-8703(72)90090-7 · Cited by 1,329
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581 · cited 1×
“Essentially identical findings were observed when the relationship between plasma asymmetric dimethylarginine (ADMA) concentration and insulin-mediated glucose disposal was evaluated (36).”
BackgroundSelf-citationInsulin resistance is a characteristic feature of primary hypertension independent of obesity
Pollare, T., Lithell, H., & Berne, C. (1990) · Metabolism · doi:10.1016/0026-0495(90)90071-j · Cited by 530 · cited 1×
“On the basis of these and other findings (7), approximately 50% of patients with essential hypertension can be considered to be insulin resistant and hyperinsulinemic.”
BackgroundRacial Differences in the Relation between Blood Pressure and Insulin Resistance
Saad, M. F., Lillioja, S., Nyomba, B. L., Castillo, C., Ferraro, R., De Gregorio, M., Ravussin, E., Knowler, W. C., Bennett, P. H., Howard, B. V., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241105 · Cited by 421
Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*
SHEN, D.-C., SHIEH, S.-M., FUH, M. M.-T., WU, D.-A., CHEN, Y.-D. I., & REAVEN, G. M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-3-580 · Cited by 420
Self-citationYeni-Komshian, H., Carantoni, M., Abbasi, F., & Reaven, G. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.171 · Cited by 414 · cited 1×
“Resistance to insulin-mediated glucose disposal and compensatory hyperinsulinemia are continuous variables (25), not dichotomous ones, and there is no simple way to classify a person as being insulin resistant or insulin sensitive.”
BackgroundSelf-citation
Research works printed but not linked: 1
- Reaven, 1993, Treatment of hypertension; focus on prevention of coronary heart disease., J Clin Endocrinol Metab, 76, 537
Cited by
Items 201–289 of 289
Samad, M. B., Hasan, M. N., Banarjee, S., Rahman, M. M., Raihan, S., Banti, F. L., Sayfe, S. S., Hasan, S. M. N., Akhter, F., Kabir, A. U., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.113 · Cited by 4
Golden, S. H., & Chong, R. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0007-7 · Cited by 4
“Although it remains controversial as to whether elevated blood pressure is a consistent feature of the insulin resistance syndrome, the coexistence of insulin resistance in the setting of hypertension is very likely central to the development of cardiovascular disease [ 19 ].”
BackgroundErtuğlu, L. A., Demirci, M., Mutchler, A. P., Laffer, C. L., Saleem, M., Ikizler, T. A., & Kirabo, A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf556 · Cited by 3
“Salt sensitivity is also strongly associated with insulin resistance (1), independent of confounding factors, including age and obesity (2).”
Pharmacological and Nutritional Benefits of Flaxseed’s (Linum usitatissimum Linn.) Biocomponents
Tarique, M., Badruddeen, B., Parveen, S., Ahsan, F., Khan, M. I., Akhtar, J., Khalid, M., Gazanfer, & Muztaba, M. (2022) · Current Functional Foods · doi:10.2174/2666862901666220106140913 · Cited by 3
Yarube, I. U., Ayo, J. O., Magaji, R. A., Umar, I. A., Yusuf, N., Alhassan, A. W., & Saleh, M. I. A. (2016) · Journal of African Association of Physiological Sciences · Cited by 4
Adireddy, V., Bimireddy, B. P. K., & Ponneri, V. (2017) · Biomedical Chromatography · doi:10.1002/bmc.4027 · Cited by 3
Meysamie, A., Ghalehtaki, R., Ghodsi, S., Mohebi, M., Ghalehtaki, S., Salarvand, F., Hosseini, Z., & Sadre‐Bafghi, S. (2021) · PubMed Central · doi:10.22088/cjim.12.3.327 · Cited by 3
“Caspian J Intern Med 2021; 12(3):327-335 328 Meysamie A, et al.”
InfluentialNazare, J., Balkau, B., & Borel, A. (2017) · Contemporary diabetes · doi:10.1007/978-3-319-61013-9_3 · Cited by 3
Consenso latinoamericano de hipertensión en pacientes con Diabetes tipo 2 y síndrome metabólico
López-Jaramillo, P. A. (2013) · Acta Médica Colombiana · doi:10.36104/amc.2013.272 · Cited by 11
Rosas, M., Pastelín, G., Vargas‐Alarcón, G., Martínez-Réding, J., Lomelí, C., Mendoza-González, C., Lorenzo, J. A., Méndez, A. J., Franco, M., Sánchez‐Lozada, L. G., et al. (2008) · REMERI - Red Mexicana de Repositorios Institucionales · Cited by 3
Syndrome métabolique : diagnostic, conséquences cardiaques et vasculaires
Tison, E. (2005) · EMC - Cardiologie-Angéiologie · doi:10.1016/j.emcaa.2005.09.001 · Cited by 9
The Sympatho-Adrenal System in the Metabolic Syndrome
Landsberg, L. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_6 · Cited by 3
Kratochvílová, S., Vyhnanovská, P., Vlasáková, Z., Hájek, M., Skibová, J., & Pelikánová, T. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.010 · Cited by 3
Aghasadeghi, K., Ahmadi, A., Zibaeenezhad, M. J., Heydari, S. T., Abtahi, F., Zamirian, M., Khosropanah, S., Moaref, A., & Babaeebigi (2011) · International Cardivascular Research Journal · Cited by 3
Consenso latinoamericano de hipertensión en pacientes con diabetes tipo 2 y síndrome metabólico
López-Jaramillo, P. A., Sánchez, R., Díaz, M., Cobos, L., Brice, A., Carrillo, J. Z. P., Lizcano, F., Lanas, F. T., Sinay, I. R., Sierra, I. D., et al. (2013) · Revista Med · doi:10.18359/rmed.1164 · Cited by 5
The Insulin Resistance Syndrome: Concept and Therapeutic Approaches
Reaven, G. M. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_3 · Cited by 4
Self-citationUsing Insulin as a Drug Rather Than as a Replacement Hormone During Acute Illness: A New Paradigm
Pantaleo, A., & Zonszein, J. (2003) · Heart Disease · doi:10.1097/01.hdx.0000089839.13906.63 · Cited by 3
Yoo, H. L. (2007) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/rtd-180813-16226 · Cited by 6
Мамедов, М. Н., Gorbunov, V. M., & Джахангиров, Т. Ш. (2006) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2006-2-1-11-17 · Cited by 2
Schaalan, M. F. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000477 · Cited by 2
Youssef, S. M. (2013) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000119 · Cited by 2
Síndrome metabólico: ¿Queda espacio para este concepto?
Rivas, G., & Pablo, J. (2012) · Revista Venezolana de Endocrinología y Metabolismo · Cited by 6
Zhang, Z., Zhang, F., Xu, Q., Li, X., & Zhong, Y. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2572389 · Cited by 1
“Meanwhile, metabolic disorders such as insulin resistance may be an important bridge between abnormal kidney function and hypertension [28,29]. therefore, exploring the association between ΔeGFR CysC–Scr , tyG and hypertension not only contributes to a deeper understanding of the pathogenesis of…”
Predictors of Kidney Disease in Diabetic, Hypertensive Patients
Buddineni, J. P., Chaudhary, K. R., & Whaley‐Connell, A. T. (2012) · Humana Press eBooks · doi:10.1007/978-1-60327-357-2_9 · Cited by 1
Inflation of diagnostic tests in hypertensive young adults: a need for diagnostic guideline?
Kırkpantur, A., Arıcı, M., Altun, B., & Turgan, Ç. (2009) · Open Medicine · doi:10.2478/s11536-009-0003-z · Cited by 1
“Previously, it has been reported that the prevalence of insulin resistance/hyperinsulinemia is increased in patients with primary hypertension and insulin resistance/hyperinsulinemia have been shown in prospective studies to be independent predictors of the development of primary hypertension [21].”
BackgroundOcena stężenia wybranych adipocytokin u chorych z zespołem metabolicznym i nadciśnieniem tętniczym
Foremska-Iciek, J. (2010) · Biblioteka Uniwersytetu Medycznego w Poznaniu · Cited by 1
Maki, K. C. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-533-6_4 · Cited by 1
Complications of Obesity: Metabolic Syndrome
Osganian, S. K., de Ferranti, S. D., Duggan, C. R., Watkins, J. B., & Walker, W. A. (2008) · Cited by 1
Phanzu, B. K., Longo‐Mbenza, B., On'kin, J. B. K. L., Pukuta, J. M., Vita, E. K., & Kianu, N. M. M. (2014) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2014.413076 · Cited by 1
“Thus, hypertensive patients with insulin resistance are at greater risk of cardiovascular disease and may represent a particular subset of HTN requiring special medical attention [20] [37]-[40].”
BackgroundInitiating insulin in type 2 diabetes mellitus: the earlier the better.
Cohen, O. (2004) · PubMed · Cited by 1
Hypertension in the Pediatric Intensive Care Unit
Sanders, R. C., ZARITSKY, A. L., & McNiece, K. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-07307-3.10073-4 · Cited by 1
Kulik, V. V., Бабийчук, Г. А., Бабийчук, В. Г., Малова, Н. Г., & Sirotenko, L. A. (2019) · Problems of Cryobiology and Cryomedicine · doi:10.15407/cryo29.03.206 · Cited by 1
“), которые характерны для людей пожилого возраста [19, 23].”
BackgroundMetabolic syndrome in general medical practice
Кravets, Y. B., Samoilova, Y. G., Матюшева, Н. Б., Bulanova, A. A., Dorokhova, V. V., & Yadmaa, O. (2008) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2008-1-80-87 · Cited by 6
Grundy, S. M. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_3-2 · Cited by 2
Chaoji, S. (2023) · Vidarbha Journal of Internal Medicine · doi:10.25259/vjim_41_2022 · Cited by 2
Патогенетичні механізми проатерогенних змін у вагітних з супутнім ожирінням
Тарасенко, К. В., & Mamontova, T. V. (2013) · Likarska sprava · doi:10.31640/ls-2013-8-04 · Cited by 1
Babiichuk, L. V., Babiychuk, V. G., Sirotenko, L. A., Malova, N., & Koval, S. (2014) · Genes and Cells · doi:10.23868/gc120396 · Cited by 1
Trends in mean serum insulin and hyperinsulinemia among US adults without diabetes 1999–2018
Johnson, T. M., & Churilla, J. R. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109159 · Cited by 1
LEIPER, J. M., Arrigoni, F., & Ahmetaj, B. (2011) · Springer eBooks · doi:10.1007/978-0-85729-920-8_5 · Cited by 1
“Mice lacking eNOS are salt sensitive [ 148 ] and the effects of endogenous NOS inhibitors can induce kidney-mediated salt-sensitive hypertension in rats [ 149 ] .”
BackgroundCalderón, M. R., Garber, I. L., Guifarro, M. A. R., Espinosa-Aguilar, L., & Campos, F. M. (2009) · Anales Médicos de la Asociación Médica del Centro Médico ABC · Cited by 1
Brennan, A., Sweeney, L. L., & Mantzoros, C. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_3 · Cited by 2
Smith, W. T. (2006) · SUNScholar (Stellenbosch University) · Cited by 2
Chaiken, R. L., & Banerji, M. A. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_9 · Cited by 2
Hypertension and Atherosclerosis: Advanced Glycation End Products—A Common Link
Vasdev, S., & Gill, V. D. (2006) · Springer eBooks · doi:10.1007/0-387-36279-3_14
The Effects of Oats and Oat‐β‐Glucan on Blood Lipoproteins and Risk for Cardiovascular Disease
Rains, T. M., & Maki, K. C. (2013) · Wiley eBooks · doi:10.1002/9781118354100.ch9
Factors in the Increasing Prevalence of Hypertension
Hyder, J. A. (2003) · JAMA · doi:10.1001/jama.290.22.2940-a
Physical activity, inherited characteristics, and hypertension
Hernelahti, M. (2004) · Helda - University of Helsinki Institutional Repository · Cited by 2
From the pancreatic beta cell to the endothelium:Pathophysiological aspects of Type 2 Diabetes
Nitert, M. D. (2007) · Lund University Publications (Lund University)
Fatores de risco para a elevação da pressão arterial em adolescentes
Fonseca, L. S., & Kirsten, V. R. (2010) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v43i4p400-407 · Cited by 4
Hiperinsulinemia y cambios en el espesor intima media de la pared arterial
Vergara, M. A. (2007) · Americanae (AECID Library)
The Border of Internal Medicine and Metabolic Surgery
Karcz-Socha, I. (2012) · Springer eBooks · doi:10.1007/978-3-642-02411-5_9
Veränderungen der Insulinsensitivität und -resistenz
Heinze, E. (2005) · Springer eBooks · doi:10.1007/3-540-26775-1_18
Syndrome métabolique : diagnostic, conséquences cardiaques et vasculaires
Tison, E. (2005) · EMC - Cardiologie · doi:10.1016/s1166-4568(05)41772-6 · Cited by 1
Идрисова, Е. М., Kalashnikova, T. P., & Efimova, I. Y. (2009) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2009-5-5-53-58
Mieczkowska, J., Mosiewicz, J., Kwaśniewski, W. M., & Rymarz, E. (2012) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2012.31462
Guías clínicas para la detección, prevención, diagnóstico y tratamiento de hipertensión arterial
Rosas, M., Pastelín, G., Vargas‐Alarcón, G., Martínez-Réding, J., Lomelí, C., Mendoza-González, C., Lorenzo, J. A., Méndez, A. J., Franco, M., Verdejo, J., et al. (2008)
Мамедов, М. Н., Эктова, Т. В., Litinskaya, O. A., Sh, T., Косматова, О. В., & Abdullaev, D. M. (2006) · CyberLeninK (CyberLeninka)
Insulin Resistance, Obesity, Body Fat Distribution, and Risk of Cardiovascular Disease
Shetty, G. K., & Mantzoros, C. S. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420018905.003
Benya, M. K. (2015) · Scholar Commons (University of South Carolina)
Ho, H. V. T. (2015) · TSpace (University of Toronto) · Cited by 1
Wearn, J. G. (2010) · VTechWorks (Virginia Tech)
KOVALYOVA, A. O., Panova, E. I., MOROZOVA, E. P., Жданкина, Н. В., Николаевна, К. О., & PETROV, S. A. (2017) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2017.10(4).37-43
PMI 5011 regulates the ubiquitin proteasome system in skeletal muscle
Kirk-Ballard, H. (2012) · Louisiana State University · doi:10.31390/gradschool_dissertations.1084
“This decreased cellular response to insulin or perturbation of the insulin signaling pathways are associated with a number of pathological states (Taylor, 1992), including cardiovascular diseases such as atherosclerosis and hypertension (Savage, et al., 2005; Reaven, 2003).”
BackgroundМамедов, М. Н. (2005) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2005-11-3-173-176
Clinical and functional features of thyroid gland dysfunction combined with metabolic syndrome
Fateevа, A. A., Martirosyan, N., & Petunina, N. A. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-4-100-104
Wang, Y. (2019) · The Atrium (University of Guelph)
The Cardiovascular Consequences of Type 2 Diabetes Mellitus
Golden, S. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_5 · Cited by 2
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., Lam, M. L., & Chaiken, R. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_34
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., & Lam, M. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_34-1
Grundy, S. M. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_3-1 · Cited by 1
Team DFTB (2013) · Don't Forget The Bubbles · doi:10.31440/dftb.3011
Correlation of Dysmetabolic Risk Factors with Different Anthropometric Measurements
Keshteli, A. H., & Chehrei, A. (2006) · Endocrine Journal · doi:10.1507/endocrj.k06-110
Features of the formation of menopausal metabolic syndrome in arterial hypertension
Ruyatkina, L. A., Ruyatkin, D. S., & Щербакова, Л. В. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-23-357-365
Factores de riesgo coronario en adolescentes
Ponce, R. D. S. (2006) · Revista Peruana de Pediatría · doi:10.61651/rped.2006v59n1p34-40 · Cited by 2
“Niños y adolescentes con sobrepeso generalmente tienen algún grado de resistencia a la insulina (27) , encontrándose que el 30 % de niños y adolescentes con índice de masa corporal (IMC) por encima del 95 percentil tienen sindrome de resistencia a la insulina (28) .”
BackgroundMarta, W.-G. (2013) · Biblioteka Uniwersytetu Medycznego w Poznaniu
Mehrhof, S. Z. (2024) · Apollo (University of Cambridge) · doi:10.17863/cam.117708
Mir, F. A., Mall, R., Ullah, E., Iskandarani, A., Cyprian, F., Samra, T. A., Alkasem, M., Abdalhakam, I., Farooq, F., Taheri, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22626289
Alterações cardiovasculares induzidas pelo aumento da ingestão de sal ou de sacarose
Moreira, M. C. D. S. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Cathestatin and metabolic syndrome in patients with hypertension
Shvan, L. Y., Gubareva, I. V., Александрович, Т. С., & Gubareva, E. U. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-235-3-152-157
Etude des adipokines en relation avec le syndrome métabolique et l'inflammation
Samara, A. (2008) · theses.fr (ABES) · doi:10.70675/5a2e0cdcz6d0az4e3cz9302z61287571b777
Djohan, Y. F. (2017) · theses.fr (ABES) · doi:10.70675/d5731089zdcf9z4aefza338z8affdb118a6f · Cited by 1
Lee, S., Cho, S. J., Park, J. A., Baek, S., Rhee, Y., & Hong, N. (2026) · Hypertension Research · doi:10.1038/s41440-026-02735-0
Efecto dual de los aminoácidos de cadena ramificada y su relación con la resistencia a la insulina
Lagos, F. P. (2022) · MLS Health & Nutrition Research · doi:10.60134/prfk3249
Pharmacoeconomical basis of combination therapy in hypertensive patients with metabolic syndrome
Сидоренкова, Н. Б., Manukyan, A., & Георгиевна, Ж. О. (2009) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2009-15-3-366-372
Metadata
- Authors
- Reaven, G. M.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Reaven, Gerald M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 88
- Issue
- 6
- Pages
- 2399-2403
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2033704972
- Semantic Scholar
- 273ddc01929a0f425076be991fd96bb78d531c52
- Cited by
- 284
- References
- 43
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 7 · 2019: 4 · 2018: 7 · 2017: 12 · 2016: 8 · 2015: 7 · 2014: 10 · 2013: 17 · 2012: 14
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- insulin resistance, compensatory hyperinsulinemia, essential hypertension, cardiovascular disease, blood pressure regulation, insulin-stimulated glucose disposal, fasting insulin
- MeSH terms
- Adaptation, Physiological, Cardiovascular Diseases, Humans, Hyperinsulinism, Hypertension, Insulin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.